Despite strong Service and other revenues, PacBio reports soft fourth-quarter 2024 results partly due to lower Revio system ...

Canaccord reiterates a Buy rating on PacBio (PACB) with a $3 price target following the company’s Q4 report. The firm says that although PacBio ...

SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory ...

PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024. Fourth quarter results Revenue of ...

Despite a challenging macroeconomic environment, Pacific Biosciences of California Inc (PACB) reports strategic growth and ...

The Japanese investment holding company SoftBank Group ( OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California ( PACB ), and 14.66M shares in Recursion ...

Friday's market has seen significant movements in a range of stocks, with some experiencing sharp increases while others face ...

Friday's market has seen significant activity with stocks like Alibaba-exch (BABA) advancing, while Procter & Gamble (NYSE:PG ...